Global Mendelian Disorders Testing Market Research Report 2023

Report ID: 1988642 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Mendelian Disorders Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Carrier Testing
        1.2.3 Diagnostic Testing
        1.2.4 New-Born Screening
        1.2.5 Predictive & Pre-Symptomatic Testing
        1.2.6 Prenatal Testing
    1.3 Market by Application
        1.3.1 Global Mendelian Disorders Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Specialty Clinc
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Mendelian Disorders Testing Market Perspective (2017-2028)
    2.2 Mendelian Disorders Testing Growth Trends by Region
        2.2.1 Mendelian Disorders Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Mendelian Disorders Testing Historic Market Size by Region (2017-2022)
        2.2.3 Mendelian Disorders Testing Forecasted Market Size by Region (2023-2028)
    2.3 Mendelian Disorders Testing Market Dynamics
        2.3.1 Mendelian Disorders Testing Industry Trends
        2.3.2 Mendelian Disorders Testing Market Drivers
        2.3.3 Mendelian Disorders Testing Market Challenges
        2.3.4 Mendelian Disorders Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Mendelian Disorders Testing Players by Revenue
        3.1.1 Global Top Mendelian Disorders Testing Players by Revenue (2017-2022)
        3.1.2 Global Mendelian Disorders Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Mendelian Disorders Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Mendelian Disorders Testing Revenue
    3.4 Global Mendelian Disorders Testing Market Concentration Ratio
        3.4.1 Global Mendelian Disorders Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mendelian Disorders Testing Revenue in 2021
    3.5 Mendelian Disorders Testing Key Players Head office and Area Served
    3.6 Key Players Mendelian Disorders Testing Product Solution and Service
    3.7 Date of Enter into Mendelian Disorders Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Mendelian Disorders Testing Breakdown Data by Type
    4.1 Global Mendelian Disorders Testing Historic Market Size by Type (2017-2022)
    4.2 Global Mendelian Disorders Testing Forecasted Market Size by Type (2023-2028)
5 Mendelian Disorders Testing Breakdown Data by Application
    5.1 Global Mendelian Disorders Testing Historic Market Size by Application (2017-2022)
    5.2 Global Mendelian Disorders Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Mendelian Disorders Testing Market Size (2017-2028)
    6.2 North America Mendelian Disorders Testing Market Size by Country (2017-2022)
    6.3 North America Mendelian Disorders Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Mendelian Disorders Testing Market Size (2017-2028)
    7.2 Europe Mendelian Disorders Testing Market Size by Country (2017-2022)
    7.3 Europe Mendelian Disorders Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Mendelian Disorders Testing Market Size (2017-2028)
    8.2 Asia-Pacific Mendelian Disorders Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Mendelian Disorders Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Mendelian Disorders Testing Market Size (2017-2028)
    9.2 Latin America Mendelian Disorders Testing Market Size by Country (2017-2022)
    9.3 Latin America Mendelian Disorders Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Mendelian Disorders Testing Market Size (2017-2028)
    10.2 Middle East & Africa Mendelian Disorders Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Mendelian Disorders Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Celera Group
        11.1.1 Celera Group Company Detail
        11.1.2 Celera Group Business Overview
        11.1.3 Celera Group Mendelian Disorders Testing Introduction
        11.1.4 Celera Group Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.1.5 Celera Group Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Detail
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories Mendelian Disorders Testing Introduction
        11.2.4 Abbott Laboratories Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.2.5 Abbott Laboratories Recent Development
    11.3 ELITech Group
        11.3.1 ELITech Group Company Detail
        11.3.2 ELITech Group Business Overview
        11.3.3 ELITech Group Mendelian Disorders Testing Introduction
        11.3.4 ELITech Group Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.3.5 ELITech Group Recent Development
    11.4 Quest Diagnostics
        11.4.1 Quest Diagnostics Company Detail
        11.4.2 Quest Diagnostics Business Overview
        11.4.3 Quest Diagnostics Mendelian Disorders Testing Introduction
        11.4.4 Quest Diagnostics Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.4.5 Quest Diagnostics Recent Development
    11.5 AutoGenomics
        11.5.1 AutoGenomics Company Detail
        11.5.2 AutoGenomics Business Overview
        11.5.3 AutoGenomics Mendelian Disorders Testing Introduction
        11.5.4 AutoGenomics Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.5.5 AutoGenomics Recent Development
    11.6 PerkinElmer
        11.6.1 PerkinElmer Company Detail
        11.6.2 PerkinElmer Business Overview
        11.6.3 PerkinElmer Mendelian Disorders Testing Introduction
        11.6.4 PerkinElmer Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.6.5 PerkinElmer Recent Development
    11.7 Roche Diagnostics
        11.7.1 Roche Diagnostics Company Detail
        11.7.2 Roche Diagnostics Business Overview
        11.7.3 Roche Diagnostics Mendelian Disorders Testing Introduction
        11.7.4 Roche Diagnostics Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.7.5 Roche Diagnostics Recent Development
    11.8 Bio-Rad Laboratories
        11.8.1 Bio-Rad Laboratories Company Detail
        11.8.2 Bio-Rad Laboratories Business Overview
        11.8.3 Bio-Rad Laboratories Mendelian Disorders Testing Introduction
        11.8.4 Bio-Rad Laboratories Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.8.5 Bio-Rad Laboratories Recent Development
    11.9 Applied Biosystems
        11.9.1 Applied Biosystems Company Detail
        11.9.2 Applied Biosystems Business Overview
        11.9.3 Applied Biosystems Mendelian Disorders Testing Introduction
        11.9.4 Applied Biosystems Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.9.5 Applied Biosystems Recent Development
    11.10 Transgenomic
        11.10.1 Transgenomic Company Detail
        11.10.2 Transgenomic Business Overview
        11.10.3 Transgenomic Mendelian Disorders Testing Introduction
        11.10.4 Transgenomic Revenue in Mendelian Disorders Testing Business (2017-2022)
        11.10.5 Transgenomic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Mendelian Disorders Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Carrier Testing
    Table 3. Key Players of Diagnostic Testing
    Table 4. Key Players of New-Born Screening
    Table 5. Key Players of Predictive & Pre-Symptomatic Testing
    Table 6. Key Players of Prenatal Testing
    Table 7. Global Mendelian Disorders Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Mendelian Disorders Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Mendelian Disorders Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Mendelian Disorders Testing Market Share by Region (2017-2022)
    Table 11. Global Mendelian Disorders Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Mendelian Disorders Testing Market Share by Region (2023-2028)
    Table 13. Mendelian Disorders Testing Market Trends
    Table 14. Mendelian Disorders Testing Market Drivers
    Table 15. Mendelian Disorders Testing Market Challenges
    Table 16. Mendelian Disorders Testing Market Restraints
    Table 17. Global Mendelian Disorders Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Mendelian Disorders Testing Market Share by Players (2017-2022)
    Table 19. Global Top Mendelian Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mendelian Disorders Testing as of 2021)
    Table 20. Ranking of Global Top Mendelian Disorders Testing Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Mendelian Disorders Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Mendelian Disorders Testing Product Solution and Service
    Table 24. Date of Enter into Mendelian Disorders Testing Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Mendelian Disorders Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Mendelian Disorders Testing Revenue Market Share by Type (2017-2022)
    Table 28. Global Mendelian Disorders Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Mendelian Disorders Testing Revenue Market Share by Type (2023-2028)
    Table 30. Global Mendelian Disorders Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Mendelian Disorders Testing Revenue Market Share by Application (2017-2022)
    Table 32. Global Mendelian Disorders Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Mendelian Disorders Testing Revenue Market Share by Application (2023-2028)
    Table 34. North America Mendelian Disorders Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Mendelian Disorders Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Mendelian Disorders Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Mendelian Disorders Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Mendelian Disorders Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Mendelian Disorders Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Mendelian Disorders Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Mendelian Disorders Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Mendelian Disorders Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Mendelian Disorders Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Celera Group Company Detail
    Table 45. Celera Group Business Overview
    Table 46. Celera Group Mendelian Disorders Testing Product
    Table 47. Celera Group Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 48. Celera Group Recent Development
    Table 49. Abbott Laboratories Company Detail
    Table 50. Abbott Laboratories Business Overview
    Table 51. Abbott Laboratories Mendelian Disorders Testing Product
    Table 52. Abbott Laboratories Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 53. Abbott Laboratories Recent Development
    Table 54. ELITech Group Company Detail
    Table 55. ELITech Group Business Overview
    Table 56. ELITech Group Mendelian Disorders Testing Product
    Table 57. ELITech Group Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 58. ELITech Group Recent Development
    Table 59. Quest Diagnostics Company Detail
    Table 60. Quest Diagnostics Business Overview
    Table 61. Quest Diagnostics Mendelian Disorders Testing Product
    Table 62. Quest Diagnostics Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 63. Quest Diagnostics Recent Development
    Table 64. AutoGenomics Company Detail
    Table 65. AutoGenomics Business Overview
    Table 66. AutoGenomics Mendelian Disorders Testing Product
    Table 67. AutoGenomics Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 68. AutoGenomics Recent Development
    Table 69. PerkinElmer Company Detail
    Table 70. PerkinElmer Business Overview
    Table 71. PerkinElmer Mendelian Disorders Testing Product
    Table 72. PerkinElmer Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 73. PerkinElmer Recent Development
    Table 74. Roche Diagnostics Company Detail
    Table 75. Roche Diagnostics Business Overview
    Table 76. Roche Diagnostics Mendelian Disorders Testing Product
    Table 77. Roche Diagnostics Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 78. Roche Diagnostics Recent Development
    Table 79. Bio-Rad Laboratories Company Detail
    Table 80. Bio-Rad Laboratories Business Overview
    Table 81. Bio-Rad Laboratories Mendelian Disorders Testing Product
    Table 82. Bio-Rad Laboratories Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 83. Bio-Rad Laboratories Recent Development
    Table 84. Applied Biosystems Company Detail
    Table 85. Applied Biosystems Business Overview
    Table 86. Applied Biosystems Mendelian Disorders Testing Product
    Table 87. Applied Biosystems Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 88. Applied Biosystems Recent Development
    Table 89. Transgenomic Company Detail
    Table 90. Transgenomic Business Overview
    Table 91. Transgenomic Mendelian Disorders Testing Product
    Table 92. Transgenomic Revenue in Mendelian Disorders Testing Business (2017-2022) & (US$ Million)
    Table 93. Transgenomic Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mendelian Disorders Testing Market Share by Type: 2021 VS 2028
    Figure 2. Carrier Testing Features
    Figure 3. Diagnostic Testing Features
    Figure 4. New-Born Screening Features
    Figure 5. Predictive & Pre-Symptomatic Testing Features
    Figure 6. Prenatal Testing Features
    Figure 7. Global Mendelian Disorders Testing Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Specialty Clinc Case Studies
    Figure 10. Others Case Studies
    Figure 11. Mendelian Disorders Testing Report Years Considered
    Figure 12. Global Mendelian Disorders Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Mendelian Disorders Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Mendelian Disorders Testing Market Share by Region: 2021 VS 2028
    Figure 15. Global Mendelian Disorders Testing Market Share by Players in 2021
    Figure 16. Global Top Mendelian Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mendelian Disorders Testing as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Mendelian Disorders Testing Revenue in 2021
    Figure 18. North America Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Mendelian Disorders Testing Market Share by Country (2017-2028)
    Figure 20. United States Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Mendelian Disorders Testing Market Share by Country (2017-2028)
    Figure 24. Germany Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Mendelian Disorders Testing Market Share by Region (2017-2028)
    Figure 32. China Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Mendelian Disorders Testing Market Share by Country (2017-2028)
    Figure 40. Mexico Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Mendelian Disorders Testing Market Share by Country (2017-2028)
    Figure 44. Turkey Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Mendelian Disorders Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Celera Group Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 47. Abbott Laboratories Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 48. ELITech Group Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 49. Quest Diagnostics Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 50. AutoGenomics Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 51. PerkinElmer Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 52. Roche Diagnostics Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 54. Applied Biosystems Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 55. Transgenomic Revenue Growth Rate in Mendelian Disorders Testing Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celera Group
Abbott Laboratories
ELITech Group
Quest Diagnostics
AutoGenomics
PerkinElmer
Roche Diagnostics
Bio-Rad Laboratories
Applied Biosystems
Transgenomic
Frequently Asked Questions
Mendelian Disorders Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Mendelian Disorders Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Mendelian Disorders Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Meniere’s Disease

Meniere’s Disease market is segmented by players, region (country), by Treatment and by Applica ... Read More

Menopause Treatment

Menopause Treatment market is segmented by players, region (country), by Type and by Application. ... Read More